US FDA was set to authorize COVID-19 vaccine from Pfizer and BioNTech.
The Food and Drug Administration in the United States (US FDA) on Friday said that it was rapidly working to issue an emergency use authorization (EUA) for COVID-19 vaccine from Pfizer and BioNTech.
This, as the New York Times reported that the “green light” would possibly come as soon as Friday evening (US time).
Citing people familiar with the US FDA’s planning, the New York Times reported that the Food and Drug Administration was likely to issue an emergency use authorization by Friday evening (US time).
It had also reported on Thursday night that the Food and Drug Administration would announce the news on Saturday (US time).
READ ALSO: US President Trump Pushes For Fast Approval On COVID-19 Vaccine From Pfizer, BioNTech
Swift clearance of the coronavirus vaccine was widely expected after an advisory panel of US FDA endorsed its emergency use in order to help stem a coronavirus pandemic that had killed over 285,000 people in the United States.
The said decision would set the stage for the first Americans to be vaccinated outside of clinical trials as soon as Monday or Tuesday, with health care workers and nursing home residents were expected to be among the first in line.
Meanwhile, President Donald Trump piled pressure on US FDA to quickly approve the COVID-19 vaccine Pfizer and BioNTech.
[UPDATE] The Food and Drug Administration in the United States (US FDA) announced that it officially authorized the use of COVID-19 vaccine from Pfizer and BioNTech.
For more news and updates, you may feel free to visit this site more often. You may also visit Newspapers.ph via official Facebook page and YouTube channel.
